Parkinson disease (PD) is now regarded as a mixed motor, nonmotor and multiorgan disorder rather than a pure movement disorder. Nonmotor symptoms (NMS) have underpinned this conceptual change, and new criteria for clinical and prodromal diagnosis of PD, incorporating a range of NMS, have recently been published.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Depression in Patients with Parkinson’s Disease: Current Understanding of its Neurobiology and Implications for Treatment
Drugs & Aging Open Access 16 June 2022
-
Detailed insight into the pathophysiology and the behavioral complications associated with the Parkinson's disease and its medications
Future Journal of Pharmaceutical Sciences Open Access 15 June 2022
-
Classification of advanced stages of Parkinson’s disease: translation into stratified treatments
Journal of Neural Transmission Open Access 24 March 2017
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Parkinson, J. An Essay on the Shaking Palsy (Sherwood, Needly, and Jones, 1817).
Chaudhuri, K. R., Healy, D. G. & Schapira, A. H. Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol. 5, 235–245 (2006).
Sauerbier, A., Jenner, P., Todorova, A. & Chaudhuri, K. R. Non motor subtypes and Parkinson's disease. Parkinsonism Relat. Disord. 22, S41–S46 (2016).
Hughes, A. J., Daniel, S. E., Kilford, L. & Lees, A. J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J. Neurol. Neurosurg. Psychiatry 55, 181–184 (1992).
Hawkes, C. H. The prodromal phase of sporadic Parkinson's disease: does it exist and if so how long is it? Mov. Disord. 23, 1799–1807 (2008).
Noyce, A. J. et al. Meta-analysis of early nonmotor features and risk factors for Parkinson disease. Ann. Neurol. 72, 893–901 (2012).
Postuma, R. B. et al. MDS clinical diagnostic criteria for Parkinson's disease. Mov. Disord. 30, 1591–1601 (2015).
Berg, D. et al. MDS research criteria for prodromal Parkinson's disease. Mov. Disord. 30, 1600–1611 (2015).
Gomperts, S. N. et al. Imaging amyloid deposition in Lewy body diseases. Neurology 71, 903–910 (2008).
Schrag, A., Horsfall, L., Walters, K., Noyce, A. & Petersen, I. Prediagnostic presentations of Parkinson's disease in primary care: a case–control study. Lancet Neurol. 14, 57–64 (2015).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Chaudhuri, K., Sauerbier, A. Unravelling the nonmotor mysteries of Parkinson disease. Nat Rev Neurol 12, 10–11 (2016). https://doi.org/10.1038/nrneurol.2015.236
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneurol.2015.236
This article is cited by
-
Neurotrophin mimetics and tropomyosin kinase receptors: a futuristic pharmacological tool for Parkinson’s
Neurological Sciences (2023)
-
Detailed insight into the pathophysiology and the behavioral complications associated with the Parkinson's disease and its medications
Future Journal of Pharmaceutical Sciences (2022)
-
Depression in Patients with Parkinson’s Disease: Current Understanding of its Neurobiology and Implications for Treatment
Drugs & Aging (2022)
-
Cognitive decline in Parkinson disease
Nature Reviews Neurology (2017)
-
Classification of advanced stages of Parkinson’s disease: translation into stratified treatments
Journal of Neural Transmission (2017)